The genomic landscape of chronic lymphocytic leukemia: clinical implications

dc.contributor.author	Quesada Fernández, Víctor
dc.contributor.author	Ramsay, Andrew John
dc.contributor.author	Rodríguez Martínez, David
dc.contributor.author	Suárez Puente, Xosé Antón
dc.contributor.author	Campo, Elías
dc.contributor.author	López Otín, Carlos
dc.date.accessioned	2013-08-27T09:58:00Z
dc.date.available	2013-08-27T09:58:00Z
dc.date.issued	2013
dc.identifier.citation	BMC Medicine, 11:124 (2013); doi:10.1186/1741-7015-11-124
dc.identifier.issn	1741-7015
dc.identifier.uri	http://hdl.handle.net/10651/18743
dc.description.sponsorship	The CLL work in our laboratories is funded by the Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII and the Consolider-Ingenio RNAREG Consortium. CL-O is an Investigator with the Botín Foundation.
dc.language.iso	eng
dc.relation.ispartof	Bmc Medicine
dc.rights	(c) Quesada et al.
dc.rights	CC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	WOK
dc.title	The genomic landscape of chronic lymphocytic leukemia: clinical implications	eng
dc.type	journal article
dc.identifier.local	20130462
dc.identifier.doi	10.1186/1741-7015-11-124
dc.relation.publisherversion	http://dx.doi.org/10.1186/1741-7015-11-124
dc.rights.accessRights	open access

Este ítem está sujeto a una licencia Creative Commons